ELISA Kit for Nitric Oxide Synthase 3, Endothelial (NOS3)

ECNOS; NOS III; E-NOS; C-NOS; ENOS; CNOS; Constitutive NOS

Specificity

This assay has high sensitivity and excellent specificity for detection of Nitric Oxide Synthase 3, Endothelial (NOS3).
No significant cross-reactivity or interference between Nitric Oxide Synthase 3, Endothelial (NOS3) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Nitric Oxide Synthase 3, Endothelial (NOS3) and the recovery rates were calculated by comparing the measured value to the expected amount of Nitric Oxide Synthase 3, Endothelial (NOS3) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 97-105 101
EDTA plasma(n=5) 95-103 98
heparin plasma(n=5) 87-105 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Nitric Oxide Synthase 3, Endothelial (NOS3) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Nitric Oxide Synthase 3, Endothelial (NOS3) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Nitric Oxide Synthase 3, Endothelial (NOS3) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-104% 87-95% 79-98% 96-105%
EDTA plasma(n=5) 80-91% 87-99% 82-90% 81-99%
heparin plasma(n=5) 93-101% 81-105% 92-101% 82-98%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Reference
Journal of Ethnopharmacology Impact of matrine on inflammation related factors in rat intestinal microvascular endothelial cells ScienceDirect: S0378874109004541
PLoS One A Novel Mechanism of Formaldehyde Neurotoxicity: Inhibition of Hydrogen Sulfide Generation by Promoting Overproduction of Nitric Oxide PubMed: 23359814
6th International Scientific Interdisciplinary Conference (ISIC) Inflammation influence on the formation of endothelial dysfunction in hypertensive patients caused by obesity Knmu: Source
PLoS One. SIRT1 Gene Polymorphisms Affect the Protein Expression in Cardiovascular Diseases Plos: Source
INTERNATIONAL JOURNAL OF MEDICINE AND MEDICAL RESEARCH L-ARGININE, BUT NOT L-NAME PROTECTS AGAINST LIVER INJURY INDUCED BY EXPERIMENTAL ISCHEMIA-REPERFUSION Tdmu:Source
Journal of Clinical Laboratory Analysis Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome Pubmed:24798146
Endocrine Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia Pubmed:24840719
PLOS ONE A Remarkable Age-Related Increase in SIRT1 Protein Expression against Oxidative Stress in Elderly: PubMed: 25785999
J Trace Elem Med Biol Comparative angioprotective effects of magnesium compounds PubMed: 25127069
Journal of Functional Foods Peptides from hydrolysate of lantern fish (Benthosema pterotum) proved neuroprotective in vitro and in vivo science:S1756464616300639
Медицина и здравоохранение Роль индуцибельной NO-синтазы в механизмах регуляции функциональной активности кальций-активируемых калиевых каналов коронарных сосудов у крыс, адаптированных к стрессу article:n
journal of molecular and cellular cardiology Mutant DD genotype of NFKB1 gene is associated with the susceptibility and severity of coronary artery disease. pubmed:28088561
International Journal of Medicine and Medical Research ThE REmOdELINg Of LEfT ATRIUm ANd vAsOdILATION fAcTORs chANgEs IN IschEmIc hEART fAILURE 7038
International Journal of Ophthalmology Endothelial nitric oxide synthase deficiency influences normal cell cycle progression andapoptosis in trabecular meshwork cells. pubmed:27366677
Biomed Pharmacother. SIRT1 inhibits releases of HMGB1 and HSP70 from human umbilical vein endothelial cells caused by IL-6 and the serum from a preeclampsia patient and protects the cells from death. pubmed:28122311
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA868Hu03 Recombinant Nitric Oxide Synthase 3, Endothelial (NOS3) Positive Control; Immunogen; SDS-PAGE; WB.
RPA868Hu04 Recombinant Nitric Oxide Synthase 3, Endothelial (NOS3) Positive Control; Immunogen; SDS-PAGE; WB.
RPA868Hu01 Recombinant Nitric Oxide Synthase 3, Endothelial (NOS3) Positive Control; Immunogen; SDS-PAGE; WB.
PAA868Hu04 Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3) WB; IHC; ICC; IP.
PAA868Hu03 Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3) WB; IHC; ICC; IP.
PAA868Hu01 Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3) WB; IHC; ICC; IP.
LAA868Hu71 Biotin-Linked Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3) WB; IHC; ICC.
MAA868Hu22 Monoclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3) WB; IHC; ICC; IP.
SEA868Hu ELISA Kit for Nitric Oxide Synthase 3, Endothelial (NOS3) Enzyme-linked immunosorbent assay for Antigen Detection.